ArticleCancers2026

Plasma Sphingomyelin as a Post-Treatment Monitoring Biomarker for Pathological Response in Locally Advanced Rectal Cancer.

Pedro Brandão et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.